Copeland Capital Management LLC Has $27.38 Million Stock Holdings in iRadimed Corporation $IRMD

Key Points

• Copeland Capital Management LLC has reduced its holdings in iRadimed Corporation (NASDAQ:IRMD) by 6.7%, now owning 457,919 shares worth approximately $27.38 million.
• The company announced a quarterly dividend of $0.17 per share, yielding about 1.0%, with a payout ratio of 41.98%.
• Insider selling activity includes CEO Roger E. Susi selling 5,000 shares for $350,950, reducing his position by 0.21%.

Copeland Capital Management LLC trimmed its position in iRadimed Corporation (NASDAQ:IRMD - Free Report) by 6.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 457,919 shares of the medical equipment provider's stock after selling 32,625 shares during the quarter. Copeland Capital Management LLC owned 3.60% of iRadimed worth $27,379,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Voya Investment Management LLC grew its holdings in iRadimed by 38.2% in the 1st quarter. Voya Investment Management LLC now owns 11,711 shares of the medical equipment provider's stock valued at $615,000 after buying an additional 3,239 shares in the last quarter. Strs Ohio bought a new stake in shares of iRadimed during the 1st quarter valued at $530,000. Ellsworth Advisors LLC bought a new stake in shares of iRadimed during the 1st quarter valued at $629,000. Acadian Asset Management LLC lifted its position in shares of iRadimed by 10.9% during the 1st quarter. Acadian Asset Management LLC now owns 156,319 shares of the medical equipment provider's stock valued at $8,197,000 after acquiring an additional 15,329 shares during the period. Finally, Jane Street Group LLC bought a new stake in shares of iRadimed during the 1st quarter valued at $369,000. 92.34% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at iRadimed

In other iRadimed news, CEO Roger E. Susi sold 5,000 shares of the company's stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $70.19, for a total value of $350,950.00. Following the completion of the transaction, the chief executive officer owned 2,347,500 shares of the company's stock, valued at $164,771,025. This represents a 0.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Monty K. Allen sold 1,102 shares of the company's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $69.10, for a total value of $76,148.20. Following the completion of the transaction, the director directly owned 19,898 shares of the company's stock, valued at approximately $1,374,951.80. The trade was a 5.25% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 16,102 shares of company stock valued at $1,139,748. 36.80% of the stock is owned by corporate insiders.

iRadimed Stock Performance

NASDAQ:IRMD opened at $71.08 on Friday. The stock has a fifty day moving average price of $69.70 and a 200-day moving average price of $60.18. The company has a market cap of $904.14 million, a price-to-earnings ratio of 43.88 and a beta of 1.02. iRadimed Corporation has a fifty-two week low of $46.86 and a fifty-two week high of $74.43.

iRadimed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Monday, August 18th were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Monday, August 18th. iRadimed's dividend payout ratio is currently 41.98%.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.